A detailed history of Semmax Financial Advisors Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Semmax Financial Advisors Inc. holds 10 shares of NVO stock, worth $850. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10
Previous 10 -0.0%
Holding current value
$850
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 16, 2024

SELL
$102.11 - $135.92 $1,940 - $2,582
-19 Reduced 65.52%
10 $1,000
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $2,545 - $3,058
29 New
29 $3,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Semmax Financial Advisors Inc. Portfolio

Follow Semmax Financial Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Semmax Financial Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Semmax Financial Advisors Inc. with notifications on news.